Bringing new and more effective medications to people who need them is of critical importance today. The folks at Tekton Research play an important part in trying to do that.
Dr. Paul Pickrell of Tekton Research joined Studio 512 Co-Host Rosie Newberry to talk about a new seasonal virus clinical study Tekton is performing.
The seasonal virus Respiratory Syncytial Virus (RSV) is currently responsible for considerable hospitalizations in Austin and throughout the country.
Dr. Pickrell discussed what Respiratory Syncytial Virus (RSV) is, how serious it is for older adults, why cases of RSV have increased this year, and what we can expect this winter. He also mentioned the benefits that vaccine research offers, how many volunteers are needs, qualifications for the study, how long the study lasts, and more.
To learn more about Tekton Research and enroll in the seasonal virus clinical study, go to TektonResearch.com or call 512-812-7921. Participants will be compensated for their time and travel.
This segment is paid for by Tekton Research and is intended as an advertisement. Opinions expressed by the guest(s) on this program are solely those of the guest(s) and are not endorsed by this television station.